...Roche (SIX:ROG; OTCQX:RHHBY) launched its Ventana pan-TRK (EPR17341) assay to detect tropomyosin receptor kinase (Trk) proteins... ...all three Trk proteins, A, B and C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic
Chris Lieu
Roche
Ventana...
...In June, Roche (SIX:ROG; OTCQX:RHHBY) said FDA approved Ventana ALK (D5F3) CDx Assay as a companion... ...Pfizer and Cell Signaling Technology Inc. (Danvers, Mass.) to develop the test based on Ventana’s Ventana... ...York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana ALK (D5F3) CDx Assay Business: Diagnostic
Alex Himes
Ventana...
...Roche (SIX:ROG; OTCQX:RHHBY) received CE Mark approval for its Ventana PD-L1 (SP263) Assay to identify metastatic... ...Keytruda. Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Bristol-Myers Squibb Co. (NYSE:BMY) share rights to Opdivo. Ventana... ...enhance and score PD-L1 protein on tumor-infiltrating immune cells. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana...
...Dako A/S unit of Agilent Technologies Inc. The SP142 and SP263 assays are from Roche’s Ventana... ...Dako A/S unit of Agilent Technologies Inc. (NYSE:A), while the SP142 assay is from the Ventana...
...the comparison study is a Blueprint participant, along with FDA, EMA and research organizations. The Ventana... ...from the study will be presented Friday at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando.
Becky Simon
Ventana...
...Research (AACR), the International Association for the Study of Lung Cancer (IASLC), FDA, EMA, Roche's Ventana... ...which have not yet been disclosed. In the first phase of Blueprint, the Dako and Ventana... ...Ventana Medical Systems Inc. to develop an assay for Tecentriq atezolizumab. AstraZeneca plc also tapped Ventana...
...Roche (SIX:ROG; OTCQX:RHHBY) launched its Ventana pan-TRK (EPR17341) assay to detect tropomyosin receptor kinase (Trk) proteins... ...all three Trk proteins, A, B and C. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic
Chris Lieu
Roche
Ventana...
...In June, Roche (SIX:ROG; OTCQX:RHHBY) said FDA approved Ventana ALK (D5F3) CDx Assay as a companion... ...Pfizer and Cell Signaling Technology Inc. (Danvers, Mass.) to develop the test based on Ventana’s Ventana... ...York, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana ALK (D5F3) CDx Assay Business: Diagnostic
Alex Himes
Ventana...
...Roche (SIX:ROG; OTCQX:RHHBY) received CE Mark approval for its Ventana PD-L1 (SP263) Assay to identify metastatic... ...Keytruda. Ono Pharmaceutical Co. Ltd. (Tokyo:4528) and Bristol-Myers Squibb Co. (NYSE:BMY) share rights to Opdivo. Ventana... ...enhance and score PD-L1 protein on tumor-infiltrating immune cells. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Product: Ventana...
...Dako A/S unit of Agilent Technologies Inc. The SP142 and SP263 assays are from Roche’s Ventana... ...Dako A/S unit of Agilent Technologies Inc. (NYSE:A), while the SP142 assay is from the Ventana...
...the comparison study is a Blueprint participant, along with FDA, EMA and research organizations. The Ventana... ...from the study will be presented Friday at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando.
Becky Simon
Ventana...
...Research (AACR), the International Association for the Study of Lung Cancer (IASLC), FDA, EMA, Roche's Ventana... ...which have not yet been disclosed. In the first phase of Blueprint, the Dako and Ventana... ...Ventana Medical Systems Inc. to develop an assay for Tecentriq atezolizumab. AstraZeneca plc also tapped Ventana...
